Asked by: Mark Hoban (Conservative - Fareham)
Question to the HM Treasury:
To ask Mr Chancellor of the Exchequer, where each company seeking authorisation as a bank was located when the application was made in each of the last four years; and when each such application was determined.
Answered by Andrea Leadsom
The publication of details and statistics on new bank authorisations, and changes of control are matters for the independent financial regulators: the Prudential Regulation Authority (PRA) and Financial Conduct Authority (FCA).
The PRA and FCA published a Review of the authorisation process as part of A review of requirements for firms entering into or expanding in the banking sector: one year on, on 7 July 2014. This followed an earlier review of barriers to entry published in March 2013.
The PRA published its Annual Report and Accounts 2014 in June, which included details of the number of banks and insurance firms authorised between 1 April 2013 and 28 February 2014. The PRA has committed to publish authorisation statistics on an annual basis.
Asked by: Mark Hoban (Conservative - Fareham)
Question to the HM Treasury:
To ask Mr Chancellor of the Exchequer, if he will publish a list of each application for the change of control of a bank made in the last four years.
Answered by Andrea Leadsom
The publication of details and statistics on new bank authorisations, and changes of control are matters for the independent financial regulators: the Prudential Regulation Authority (PRA) and Financial Conduct Authority (FCA).
The PRA and FCA published a Review of the authorisation process as part of A review of requirements for firms entering into or expanding in the banking sector: one year on, on 7 July 2014. This followed an earlier review of barriers to entry published in March 2013.
The PRA published its Annual Report and Accounts 2014 in June, which included details of the number of banks and insurance firms authorised between 1 April 2013 and 28 February 2014. The PRA has committed to publish authorisation statistics on an annual basis.
Asked by: Mark Hoban (Conservative - Fareham)
Question to the HM Treasury:
To ask Mr Chancellor of the Exchequer, when his Department last conducted a review of the process of granting authorisation for (a) banks and (b) insurance companies.
Answered by Andrea Leadsom
The publication of details and statistics on new bank authorisations, and changes of control are matters for the independent financial regulators: the Prudential Regulation Authority (PRA) and Financial Conduct Authority (FCA).
The PRA and FCA published a Review of the authorisation process as part of A review of requirements for firms entering into or expanding in the banking sector: one year on, on 7 July 2014. This followed an earlier review of barriers to entry published in March 2013.
The PRA published its Annual Report and Accounts 2014 in June, which included details of the number of banks and insurance firms authorised between 1 April 2013 and 28 February 2014. The PRA has committed to publish authorisation statistics on an annual basis.
Asked by: Mark Hoban (Conservative - Fareham)
Question to the HM Treasury:
To ask Mr Chancellor of the Exchequer, what assessment he has made of the role of private equity in providing capital to the (a) banking sector and (b) insurance sector.
Answered by Andrea Leadsom
This question has been passed on to the Presidential Regulation Authority (PRA). The PRA will reply to directly to the honourable member by letter. A copy of the letter will be placed in the Library of the House.
Asked by: Mark Hoban (Conservative - Fareham)
Question to the HM Treasury:
To ask Mr Chancellor of the Exchequer, how many businesses (a) applied for and (b) were granted authorisation as insurers in each of the last five years.
Answered by Andrea Leadsom
The Prudential Regulation Authority and the Financial Conduct Authority are responsible for overseeing the authorisation of insurance companies. The Treasury does not publish data on authorisations of insurance providers.
This question has been passed on to the Financial Conduct Authority and the Prudential Regulation Authority, and they will reply directly to the honourable member by letter. A copy of the letter will be placed in the Library of the House.
Asked by: Mark Hoban (Conservative - Fareham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, with reference to the Answer to the hon. Member for Suffolk Coastal of 8 January 2014, Official Report, column 265W, on general practitioners: Suffolk, how much his Department spent funding each general practice in England in 2012-13; and what spending type and GP Practice code applies in each case.
Answered by Dan Poulter
The requested information is not collected centrally. The Investment in General Practice report published by the Health and Social Care Information Centre includes the investment in General Practice and the reimbursement of drugs dispensed in General Practices at national level. A copy has been placed in the Library.
Asked by: Mark Hoban (Conservative - Fareham)
Question to the Foreign, Commonwealth & Development Office:
To ask the Secretary of State for Foreign and Commonwealth Affairs, what recent representations he has made to his Iranian counterpart on that country's material and financial support for terror organisations.
Answered by Hugh Robertson
We have serious concerns about Iran's support for a number of militant groups in the Middle East, including Hizballah, Palestinian Islamic Jihad (PIJ), the military wing of Hamas, and Shia militia groups, including in Iraq. This support undermines prospects for peace and stability in the Middle East. We have raised our concerns about such activity during our expanding bilateral engagement with Iran, and will continue to do so.
Asked by: Mark Hoban (Conservative - Fareham)
Question to the HM Treasury:
To ask Mr Chancellor of the Exchequer, if he will make an estimate of the cost to the Exchequer of equalising the tax relief given on employee contributions to pension schemes at 30 per cent.
Answered by David Gauke
Estimates of the Exchequer effect of equalising the tax relief given on employee contributions to pension schemes at 30 per cent are not available.
Asked by: Mark Hoban (Conservative - Fareham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how much his Department spent per capita in each general practice area in Fareham constituency in the last year for which information is available.
Answered by Norman Lamb
The information is shown in the following table.
The closest geographical boundary to the question is the area covered by NHS Fareham and Gosport Clinical Commissioning Group (CCG).
Fareham and Gosport CCG General Practice spend 2013-14
General Practitioner Practice Name | Weighted List Size as at Q4 2013-14 | Total Spend 2013-14 (£) | Spend Per Capita – Weighted (£) |
Gosport Health Centre Practice | 8,638.37 | 1,336,261 | 155 |
Portchester Practice | 8,596.25 | 795,373 | 93 |
The Whiteley Surgery | 9,993.36 | 1,180,482 | 118 |
Centre Practice | 15,540.52 | 1,363,476 | 88 |
Gudgeheath Lane Surgery | 7,804.48 | 773,741 | 99 |
Jubilee Surgery | 8,259.15 | 874,108 | 106 |
Stoke Road Medical Centre | 8,752.48 | 905,412 | 103 |
Bury Road Surgery | 4,337.50 | 446,570 | 103 |
Forton Medical Centre | 9,656.23 | 1,125,220 | 117 |
Stubbington Medical Practice | 13,184.17 | 1,240,984 | 94 |
Waterside Medical Centre | 11,926.55 | 1,448,573 | 121 |
Brune Medical Centre | 8,549.08 | 1,118,871 | 131 |
Brockhurst Medical Centre | 4,345.77 | 488,803 | 112 |
Bridgemary Medical Centre | 8,503.24 | 936,475 | 110 |
Fareham Highlands Practice | 15,323.71 | 1,424,597 | 93 |
Westlands Medical Centre | 9,802.59 | 1,075,039 | 110 |
Lockswood Surgery | 10,786.16 | 1,106,611 | 103 |
Lee on the Solent Health Centre | 6,603.07 | 596,335 | 90 |
Brook Lane Surgery | 10,787.97 | 1,209,754 | 112 |
Manor Way Surgery | 4,566.91 | 444,296 | 97 |
Rowner Health Centre | 6,092.44 | 774,137 | 127 |
Totals/Average | 192,050.00 | 20,665,119 | 108 |
Source: NHS England Wessex Area Team
Note:
The average spend per capita figure of 108 is calculated as follows: Total spend 2013-14 (£20,665,119) / Total weighted list size Q4 2013-14 (192,050) = £107.60
Asked by: Mark Hoban (Conservative - Fareham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, who is responsible for auditing compliance with National Institute for Health and Care Excellence guidelines relating to the care of patients with diabetes.
Answered by Jane Ellison
The National Institute for Health and Care Excellence (NICE) is an independent organisation established by Government to provide national guidance and advice to improve health and social care. It has published clinical guidance and quality standards on the treatment of diabetes and its complications. The NICE Diabetes Quality Standard is clear that people with diabetes who are at risk of foot ulceration should receive regular reviews by a foot protection team in accordance with its clinical guidance. The Health and Social Care Act (2012) places a duty on NHS England to have regard to the NICE Quality Standards. Clinical commissioning groups (CCG) should also have regard to them in planning and delivering services, as part of a general duty to secure a continuous improvement in quality.
As part of the Quality Outcomes Framework (QOF), general practitioners are remunerated for assessing nerve damage and poor blood supply to the feet in people with diabetes on an annual basis. Information is collected annually both through QOF returns and through the National Diabetes Audit (NDA).
The NDA provides information of local practice against NICE guidelines and can be used by local areas to compare their own performance over time and against others, helping to drive service improvement. The latest published NDA report shows that more than 85% of all those with diabetes in England and Wales, received these checks in 2011-12.
In July 2014, NHS England will be launching the National Diabetes Footcare Audit. This is a new module of the NDA, and will provide information on the effectiveness and quality of the entire diabetes foot care pathway, including the elements delivered in primary, community and secondary care settings.